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ecent intense investigations have revealed the complexity
JL N. in the induction of IgE synthesis. In man, the impor-
tant role played by IIr4 has been extensively documented in
that this cytokine appears to generate an essential signal for
this process (1). However, this signal is not sufficient for resting
human B cells to initiate IgE synthesis (2, 3). In this regard,
activation signals generated in either allogeneic or autolo-
gous MLR (2, 4) and in a T cell-independent EBV infection
(5, 6) are synergistic with 1174. Both MLR and EBV infec-
tion are complex processes and are not easily amenable to
further analysis.
In an attempt to develop a T cell-independent system to
investigate the signal requirements for the induction of IgG
synthesis, we have screened a series of mAb to B cell surface
antigens to determine if they were synergistic with IL4 to
induce IgE synthesis by human B cells. Anti-CD40 mAb 626.1
has been found to potently synergize with 114 to induce IgE
synthesis. As in other IgE synthesis systems, endogenous 1176
also plays an important role.
Materials and Methods
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Summary
A novel pathway of IgE-B cell differentiation has been identified. Engagement of the B cell
antigen CD40 by F(ab')2 fragments of monoclonal antibody (mAb) 626.1 in the presence of
recombinant interleukin 4 (rIL4) induced intense IgE synthesis, but modest IgG synthesis, by
highly purified human B cells. Surface IgE- B cells isolated by cell sorting were induced to
produce IgE by mAb 626.1 and IIr4. Thus, IgE synthesis is unlikely to result from expansion
of a B cell populationprecommitted to IgE in vivo. A neutralizing anti-II76 antibody strongly,
but not completely, inhibited the IgE response. This indicates that autocrine production of Il76
plays an important amplification role in IgE synthesis triggered by anti-CD40 mAb and 1174.
Although the exact role played by CD40 in IgE responses in vivo remains to be established,
this T cell-independent system represents a useful model to characterize the biochemical and
molecular events leading to IgE synthesis in human B cells.
Reagents.
￿
F(aV)a fragments of mAb 626.1 (IgG1 anti-CD40)
were obtained as previously described (7). The sources for mAb
L243 (anti-HLA-DR), anti-Leu-16 (anti-CD20), OKB7 and HB5
(anti-CD21), anti-)A antibody, rID4, rIL6, and a neutralizing goat
IgG anti-human 11,6 antibody have been previously described
(2, 6, 8).
B Cell Cultures.
￿
Highly purified human B cells from nonatopic
subjects were prepared as previously described (2). The cultures
(106 B cells/ml) were set up as described in Results. Supernatants
were assessed by RIA for their IgE content, and by ELISA for IgM
and IgG concentrations, as previously described (3). Control cul-
turesfor the evaluationofpreformed Ig were set up in the presence
ofcyeloheximide (100,ug/ml) (Sigma Chemical Co., St. Louis, MO).
Cell Sorting.
￿
Purified B cells were labeled with FITC-conjugated
affinity-purified goat anti-humanIgE antibody (Tago Inc., Burlin-
game, CA), or with PE-conjugated anti-CD20 mAb, and sorted
on a FACStar Plus flow cytometer (Becton Dickinson & Co., Moun-
tain View, CA). Setting of the markers and analysis of the sorted
cells were performed as previously described (6).
Results
In an attempt to identify surface antigens that are impor-
tant in IgE synthesis, antibodies to B cell-specific antigens
were used in conjunction with 1174 to induce B cells to syn-
thesize IgE. Antibodies to surface IgM, CD20, CD21, and
MHC class II molecules were found to be ineffective (data
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to be a potent agent in this system. As shown in Table 1,
no IgE production was detected in cultures stimulated with
either anti-CD40-F(ab')2 or 114 alone. In contrast, substan-
tial production of IgE was consistently observed when both
rIL4 and anti-CD40 mAb were added. Similar results were
obtained in four experiments with different B cell donors.
Optimal IgE production was obtained after 10 d of culture,
using IL-4 at 100 U/ml and mAb 626.1 at 5 Ag/ml. Although
anti-CD40 mAbs have been shown to rescue B cells from
death in culture (9), cell viability was not significantly in-
creased in cultures stimulated with mAb 626.1 and IL-4, as
compared with cultures receiving IL-4 alone (data not shown).
The B cell preparations we used hadbeen rigorously depleted
of T cells, as indicated by the absence of proliferation to PHA.
Furthermore, IL4 and anti-CD40 mAb induced IgE synthesis
in B cells isolated by positive sorting for CD20 expression
(Table 1, Exp. 2). These data indicate that the production
of IgE induced by 114 and CD40 engagement by mAb is
T cell independent.
We next investigated the effect of mAb 626.1 and IL4 on
the synthesis of isotypes other than IgE. Table 2 shows that
stimulation of purified B cells with anti-CD40 mAb, in the
Table 1.
￿
Engagement of CD40 in the Presence of rIL-4 Induces
T Cell-independent Synthesis of IgE by Purified Human B Cells
Highly purified human Bcells isolated by sorting for CD20 expression.
Nil
rIL-4
anti-CD40 mAb-F(ab')2
rIL-4 + anti-CD40
mAb-F(2b')2
" Mean ± SE of results obtained in four experiments.
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absence of IL4, resulted in modest IgG synthesis,but no IgE
or IgM synthesis. When both anti-CD40 mAb and 114 were
added, IgG productionincreased only slightly further, while
large amounts of IgE were synthesized. Thus, the synergism
between IL-4 and CD40 engagement results primarily in the
induction of IgE synthesis.
To rule out the possibility that the induction of IgE syn-
thesis by IL4 and anti-CD40 mAb may primarily result from
the expansion of a small sIgE+ B cell population that has
undergone CE switching in vivo (10), purified peripheral blood
B lymphocytes were sorted into sIgE+ and sIgE- cells using
an FITC-conjugated affinity-purified goat anti-IgE antibody.
sIgE- B cells were subsequently stimulated with mAb 626.1
and rIL4. The fluorescence profile obtained in a representa-
tive sorting experimentis shown in Fig. 1. To avoid ambiguity,
gates for sorting were set so that even the most dimly stained
sIgE+ cells were excluded. Upon reanalysis, no sIgE+ cells
were detectable in the sIgE - cell population. Fig. 1, inset,
shows that rIL4 and anti-CD40-F(ab')2 induced sIgE - cells
to produce large amounts of IgE. These results indicate that
sIgE- B cell precursors are targets for IgE induction by IL4
and anti-CD40 mAb.
We have previously shown that endogenous IL6 plays an
obligatory role in the IL4-dependent induction of IgE syn-
thesis by human PBMC. A neutralizing anti-IL6 antibody
completely inhibited IgE synthesis induced by IL-4 (3). Be-
cause B cells produce IL6 after stimulation with either 114
(11) or anti-CD40 mAb (9), the role of endogenous IL-6 was
assessed in our system. Table 3 shows that a neutralizing goat
anti-I1,6 antibody, but not a control goat serum, strongly,
although not completely, inhibited IgE synthesis by human
B cells stimulated with mAb 626.1-F(ab')2 plus 11,4. Inhi-
bition by anti-I1,6 antibody was specific, because it was reversed
by addition of rIL6 (300 U/ml). These results show that
autocrine production of IL-6 is an important step in the
augmentation of IgE synthesis induced by IL-4 and anti-
CD40 mAb.
The Role of CD40 in Human IgE Synthesis
Stimulant
￿
IgE (pg/ml)
Nil
￿
< Iso
rIL-4
￿
"so
anti-CD40 mAb
￿
< 150
anti-CD40 mAb+IL-4 13,000
101 10 2 103
Relative Fluorescence Intensity
Figure 1.
￿
Flow cytometry profile obtained by staining highly purified
Bcells with FITC-conjugated affinity-purified goat anti-human IgE anti-
body (...... .), or FITC-conjugated normal goat serum (-). Analysis
for sIgE+ cells in the sIgE - populationisolated by sorting is also shown
(- - -). (Inset) IgE production by sIgE- B cells obtained by cell sorting
in a representative experiment.
Table 2. Induction of Ig Isotypes Synthesis by rIL-4 and
Anti-CD40 mAb
a
Z
Net Ig Synthesis m v IS
d
Stimulant IgM IgG IgE 1
a 1, m oc
ng/ml
54 ± 30' 55 ± 11 <0.15
14 ± 10 40 ± 11 <0.15
76 ± 40 291 ± 146 <0.15
40 ± 10 441 ± 128 43 ± 19
Stimulant Exp. 1 Exp. 2'
pg/ml
Nil <150 <150
rIL-4 <150 <150
anti-CD40 mAb-F(ab')2 <150 <150
rIL-4 + anti-CD40 mAb-F(ab')2 40,000 12,200Table 3.
￿
Anti-IL-6 Antibody Inhibits the Synthesis of IgE
Induced by anti-CD40 mAb and rIL-4
Discussion
This report describes a novel pathway of human B cell
differentiation into IgE production, which is triggered by
the engagement of the B cell antigen CD40 in the presence
of IL-4. Induction of IgE synthesis in this system is T cell
independent and primarily involves sIgE - B cells.
IL4 has been shown to induce germ-line CE transcripts
in both human (6, 12) and murine (13) B cells. This is thought
to reflect an increase in the accessibility of the E switch re-
gion, which would become the target for switch recombina-
tion. The exact role ofIL-4 in IgE isotype switching remains
to be identified. Induction of IgE synthesis by anti-CD40
mAb plus IL4 may provide a well-defined system to charac-
terize the biochemical and molecular events that underlie iso-
type switching.
CD40 is a 50-kD surface glycoprotein expressed on all
human B lymphocytes, but not on T cells and monocytes
(14). Anti-CD40 mAbs (such as mAbs G28.5 and S2C6) de-
liver a strong progression signal to resting B cells in the pres-
ence ofprimary activators (14). More recently, our anti-CD40
mAb 626.1 has been shown to induce significant prolifera-
tion of resting B cells in the absence of other costimuli (7).
Cloning of the CD40 gene has revealed that CD40 is closely
related to the receptors for nerve growth factor (15) and TNF-ci
(16). These homologies and the growth factor-like activity
of anti-CD40 mAb suggest that CD40 may be involved in
the regulation of B cell activation and growth. Thus far, the
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ligand for CD40 has not been identified. The possibility that
it may be involved in cell-cell interactions must be consid-
ered. With the identification of this ligand, the exact role
of CD40 in B cell activation in general, and in IgE synthesis
in particular, can be elucidated.
It is not clearat which step(s) the IL-4-and CD40-dependent
signaling pathways actually synergize to induce IgE produc-
tion. IL-4 has been shown to costimulate human B cells only
when combined with competence signals that activate PKC
and induce increase in intracellular calcium (17). Anti-CD40
mAb 626.1, however, does not induce calcium mobilization,
even aftercrosslinking (7). Interestingly, 11,4 has been shown
to upregulate CD40 expression on B cells(17). This upregu-
lation may amplify the signals generated by the reaction be-
tween CD40 and the mAb 626.1, and may be important for
IgE induction.
Endogenous IL6 has been shown to be required for the
T cell-dependent induction ofIgE synthesis by humanPBMC
(3). Our data suggest an important amplification role of 1176
in IgE synthesis induced by IL-4 and CD40 engagement. In-
terestingly, both IL4 and anti-CD40 mAb induced 11,6
productionin B cells (9, 11). Furthermore, IL6 increases the
phosphorylation of CD40 in human B cells, thus leading to
a CD40-IL6 loop (9). IL6 is known to act at a late stage
in B cell differentiation with no isotype preference. 11,6 in-
duces the secretion of IgG1 by coordinated transcriptional
activation, selective accumulation of mRNA for the secreted
form of IgG, and possibly differential mRNA stabilization
(18). IL6 may amplify IgE secretion by similar mechanisms.
In mice, T cell-independent synthesis of IgE can be readily
induced by stimulation with LPS and 11,4. In contrast, all
polyclonal B cell activators tested (anti-IgM antibodies, Staph-
ylococcus aureus Cowan I, phorbol esters, anti-CD20 mAb),
with the exception of EBV, have failed to synergize with 11,4
in the induction of IgE synthesis by purified human B cells
(1, 2, 5, 6). Although mAbs to the EBV receptor synergize
with anti-IgM antibodies to induce B cell activation (19),
they were unable to mimic EBV in synergizing with IL4
for IgE induction (6). Thus, to our knowledge, the system
described herein is the first one in which the B cell activating
signal required for human IgE synthesis is delivered by en-
gagement of a discrete B cell surface antigen. This further
underscores the significance of the role of CD40 in IgE syn-
thesis.
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Stimulant
Net
Exp. 1
IgE synthesis
Exp. 2
pg/ml
Nil <150 <150
rlL-4 <150 <150
anti-CD40 mAb-F(ab')2 <150 <150
rIL-4 + anti-CD40 mAb-F(ab')2 54,450 45,700
rIL-4 + anti-CD40 mAb-F(ab')2
+ anti-IL-6 antibody 3,600 4,250
rIL-4 + anti-CD40 mAb-F(ab')2
+ control serum 52,000 38,300References
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